KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to $133.0 million.

  • Bristol Myers Squibb's Share-based Compensation rose 1083.33% to $133.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $553.0 million, marking a year-over-year increase of 907.3%. This contributed to the annual value of $553.0 million for FY2025, which is 907.3% up from last year.
  • According to the latest figures from Q4 2025, Bristol Myers Squibb's Share-based Compensation is $133.0 million, which was up 1083.33% from $139.0 million recorded in Q3 2025.
  • Bristol Myers Squibb's 5-year Share-based Compensation high stood at $157.0 million for Q2 2021, and its period low was $107.0 million during Q1 2022.
  • Over the past 5 years, Bristol Myers Squibb's median Share-based Compensation value was $132.5 million (recorded in 2021), while the average stood at $130.9 million.
  • Per our database at Business Quant, Bristol Myers Squibb's Share-based Compensation tumbled by 2913.91% in 2022 and then skyrocketed by 1810.34% in 2023.
  • Over the past 5 years, Bristol Myers Squibb's Share-based Compensation (Quarter) stood at $133.0 million in 2021, then dropped by 10.53% to $119.0 million in 2022, then increased by 6.72% to $127.0 million in 2023, then fell by 5.51% to $120.0 million in 2024, then grew by 10.83% to $133.0 million in 2025.
  • Its Share-based Compensation stands at $133.0 million for Q4 2025, versus $139.0 million for Q3 2025 and $137.0 million for Q2 2025.